Eric Forrand

Eric Forrand is currently the CMC Project Quality Lead at Sanofi, overseeing quality for mRNA vaccines. Previously, they served as Quality Product Lead at bluebird bio, where they provided oversight for two gene therapy programs and supported regulatory submissions. Prior to that, they held various quality roles at Takeda, contributing to external supplier oversight and product quality representation. Eric began their career in finance at Brown Brothers Harriman before transitioning into quality management, culminating in a Master of Liberal Arts in Management from Harvard Extension School and a BS in Biology from Boston University.